Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 15 August 2016 | By Michael Mezher
Changing the supplier of gelatin capsules used to encase drugs constitutes a minor change, and does not require a prior approval supplement (PAS), according to a US Food and Drug Administration (FDA) policy that went into effect Monday.
When a drugmaker makes changes to an already approved product, including changes to its specifications, manufacturing process or label, the company must notify FDA of the change.
Depending on the seriousness of the change, (e.g., whether the change has significant, moderate or minor potential to affect the safety or efficacy of a product), FDA may require companies to get approval before instituting the change via a PAS.
However, when the change is considered minor, drugmakers are only required to notify the agency in an annual report to the agency.
According to the policy, FDA's Office of Pharmaceutical Quality (OPQ) says that merely changing the supplier of a hard gelatin capsule is a minor change and should only be included in an annual report.
The policy also states that if FDA receives a PAS containing a change in supplier, the agency will inform the supplier that the information needs only be included in an annual report.
Specifically, the policy says the annual report should include the following information:
However, FDA says that any change in the capsule's composition or appearance, including any changes in size, color, or dye, or a change from gelatin to a non-gelatin alternative, would require a PAS.
FDA
Tags: Prior Approval Supplement, Gelatin Capsules, Supplier Change
Regulatory Focus newsletters
All the biggest regulatory news and happenings.